Promising New Agents for Colorectal Cancer

Opinion statement Choosing the optimal treatment approach for patients with metastatic colorectal cancer (mCRC) demands that oncologists assess both clinical and genomic variables and individualize care based upon the findings. Clinically, choices depend on assessing the side of the colon in which t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current treatment options in oncology 2018-06, Vol.19 (6), p.29-14, Article 29
Hauptverfasser:	Das, Satya, Ciombor, Kristen K., Haraldsdottir, Sigurdis, Goldberg, Richard M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Bevacizumab Biomarkers, Tumor Chemotherapy Clinical trials Clinical Trials as Topic Colorectal cancer Colorectal carcinoma Colorectal Neoplasms - etiology Colorectal Neoplasms - pathology Colorectal Neoplasms - therapy Combined Modality Therapy Disease Susceptibility Drug Development Epidermal growth factor Epidermal growth factor receptors ErbB-2 protein Humans Immune checkpoint Irinotecan Liver diseases Lower Gastrointestinal Cancers (AB Benson Medicine Medicine & Public Health Metastases Metastasis Microsatellite Instability Mismatch repair Molecular Targeted Therapy Monoclonal antibodies Mutation Neoplasm Metastasis Neoplasm Staging Oncology Oxaliplatin Patients Raf protein Section Editor Targeted cancer therapy Topical Collection on Lower Gastrointestinal Cancers Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!